Individuals with pre-existing lung conditions like COPD and asthma may face diagnostic delays for lung cancer. (!--ref1--) The study, led by...
Vous n'êtes pas connecté
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the AmoyDx® Pan Lung Cancer PCR Panel
Individuals with pre-existing lung conditions like COPD and asthma may face diagnostic delays for lung cancer. (!--ref1--) The study, led by...
Highlights: CfDNA offers a non-invasive way to detect and monitor diseases like cancer and genetic conditions
Prime Minister Phạm Minh Chính urged Mitsui & Co., Ltd of Japan to accelerate the implementation of the Block B gas-electricity project and expand...
The holder of the throne of the world's most powerful supercomputer is held by Frontier with processing capabilities reaching the level of exaFLOPS....
What is circulating cell-free DNA, and how can it change healthcare? Discover how cfDNA offers non-invasive insights for cancer, prenatal care, and...
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced an extension of its strategic...
Lung problems like chronic bronchitis and emphysema can significantly increase your risk of developing lung cancer. Stay informed and protect your...
Lung problems like chronic bronchitis and emphysema can significantly increase your risk of developing lung cancer. Stay informed and protect your...